CD3scFv-Engineered AAV Capsid Drives Superior In Vitro and In Vivo CAR-T Cell Generation and Leads to Complete Eradication of CD19+ Tumors. // Molecular Therapy. – URL: https://www.sciencedirect.com/science/article/pii/S1525001626009408?dgcid=rss_sd_all
CD3scFv-Engineered AAV Capsid Drives Superior In Vitro and In Vivo CAR-T Cell Generation and Leads to Complete Eradication of CD19+ Tumors. Molecular Therapy. https://www.sciencedirect.com/science/article/pii/S1525001626009408?dgcid=rss_sd_all
“CD3scFv-Engineered AAV Capsid Drives Superior In Vitro and In Vivo CAR-T Cell Generation and Leads to Complete Eradication of CD19+ Tumors.” Molecular Therapy.
@article{article59104,
title = {CD3scFv-Engineered AAV Capsid Drives Superior In Vitro and In Vivo CAR-T Cell Generation and Leads to Complete Eradication of CD19+ Tumors},
journal = {Molecular Therapy},
url = {https://www.sciencedirect.com/science/article/pii/S1525001626009408?dgcid=rss_sd_all}
}